Group items tagged

In 2009, China's government announced plans to invest RMB1.13 trillion ($180 billion) in expanding and improving healthcare provision, through significant healthcare reforms. This massive spending program is rapidly expanding healthcare access for China's 1.3 billion citizens, and has implications for the pharmaceutical industry worldwide. Inside China's Healthcare Reforms: Opportunities for Multinational Pharma This comprehensive report goes deep inside China to reveal the ways that recent reforms are changing healthcare for rural and urban citizens. Numerous local experts have been consulted for their insights, including industry experts, government officials, ministry advisers, and formulary managers. The reader-friendly report explores each key aspect of healthcare reform in turn, clearly explaining what it is, why it was needed, and what progress has been made so far, and then summarising its specific implications for the Pharma industry. As well as covering recent reforms, the report also examines key reform priorities through to 2015.

The market for augmented reality in healthcare and virtual reality in healthcare, in terms of value, on the basis of offering, device type, end user, application, and geography.

Market Reports on India Provides the Trending Market Research Report on "Global Healthcare Supply Chain Management Market" under Life Sciences category. The report provides information on industry overview, market size, latest developments, industry trends, Key players, global presence, and their future prospects.

The Top 10 Healthcare Buildings Projects in North America : Project Guide contains information on the scope of the top ten healthcare buildings construction projects including project overviews and locations. The report also details project ownership and funding, gives full project descriptions, as well as information on contracts, tendering and key project contacts.

The healthcare industry in India is showing great progress. There has been considerable increase in spending on healthcare backed by the growing purchasing power of individuals. Moreover, with a lot of importance being given to preventive medication, the nutraceuticals market in India is set to flourish. It is one of the booming markets in India. Predominantly vitamins and minerals derived from oral pills were used for curing certain diseases and ailments. People today are becoming more prone to consume immunity enhancing food supplements and wellness related products. This is promoting the growth of the industry with players diversifying into production of various new varieties of products. Further assistance from the government and increasing demand from consumers will fuel growth in this market. The report begins with an introduction to the Indian nutraceuticals market and its classification on the basis of the ingredients and benefits incurred from them. This is followed by the market overview section which provides the market size and growth as well as the market share of the various segments in the market, namely, functional foods, dietary supplements and functional beverages. A detailed description of each segment in the market along with the dominant products in the particular category has also been provided. Focusing on one the major sub-segments, an overview of the probiotic market in India has been included. This segment has been highlighted owing to the fact that it is one of the most promising categories under the nutraceutical market and has huge growth potential in the near future with growing interests of players. The genesis of probiotics has been highlighted showing the types dominant in India and the key therapeutic benefits derived from them. This section also contains information regarding the market size and growth of probiotics in functional foods in India as well as the key segments and the active players in this space. The report begi

UAE healthcare industry has shown unprecedented growth in recent years and should continue its pace in the future due to public support active.

US Healthcare Information Technology (HIT) market has grown at a rapid pace in recent years because there are large deposits of new product launches and industry standards changing. With cloud computing making Buzz, HIT US market is ready to reach new heights.

The Thailand Medication & Medical Document features Business Monitor International (BMI)'s 5 and 10-year estimates for medication and health care costs and imports and exports

The report includes the pharmaceutical and health products Slovakia Business Monitor International (BMI) of '5 and 10 years for products and estimates of health expenditure and imports and exports,

Health sector in China is entering a new phase in the development of advanced infrastructure. The industry has many advantages such as a large population, a growing aging population and growing incidence of lifestyle diseases.

Croatia Pharmaceuticals and Health Report provides Business Monitor International (BMI) of '5 and 10 years for drugs and estimates of health expenditure and imports and exports, with a focus on the prospects for growth for the prescription, OTC, patented drugs and generics market segments.

BMI Belgian pharmaceutical and health Report provides industry professionals, investors and market analysts, business and financing independent forecasts and competitive intelligence is a drug and Belgian health sector.

Latvia Pharmaceuticals and Health Report features Business Monitor International (BMI) of '5 and 10 years for products and estimates of health expenditure and imports and exports, focusing on the growth outlook for prescription drug sales free and generic market segments.

The global healthcare services and medical equipment market is expected to witness significant contribution from biophotonics. Rise in aging population, key healthcare reforms and government supported initiatives, IT integration in healthcare sectoras well as increasing prevalence of chronic diseases are among the prominent factors that are driving the demand for bio photonic products across the globe.

The market remained strong in morning trade with the Sensex surging 281.73 points or 1.07 percent to 26528.52 and the Nifty climbing 84.10 points or 1.07 percent to 7926.80 supported by broadbased buying. Market expert Ambareesh Baliga sees 7,800-7,750 as good support level for the Nifty. In an interview with CNBC-TV18, he said Nifty is unlikely to go much beyond 8,000 levels. He remains positive on cyclicals and expects them to become more attractive post any market correction. According to Baliga, the next leg of market rally will be led by cyclicals. The broader markets outperformed benchmarks with the BSE Midcap and Smallcap indices rising 1.4 percent each. Advancing shares outnumbered declining ones by a ratio of 1544 to 380 on the Bombay Stock Exchange. The BSE Capital Goods, Realty, Metal, Banks, Healthcare, Power and Oil & Gas indices gained 1-1.7 percent. Hindalco and BHEL kept their top positions in the buying list, up 4.8 percent and 3.5 percent, respectively. Dr Reddy's Labs, Cipla, HDFC, Bank of Baroda, Ambuja Cements and PNB surged 2-2.6 percent. However, NTPC and Bajaj Auto were only losers in the Sensex 30 stocks.

* Risk * Urology * Waste Management BROWSE CATEGORIES Advertising & Marketing Agriculture Automotive Aviation/Aerospace Banking and Finance Biotechnology Business Consumer Goods Drinks Energy & Resources FMCG Food & Beverages Infrastructure Insurance Law Manufacturing & Construction Materials & Chemicals Metals and Minerals Pharmaceuticals & Healthcare Plastic Publishing Retail Research Shipping Telecommunications & IT Textiles Tourism Report detail Home > Market Research Reports > Pharmaceuticals & Healthcare > Asia Pacific Biotechnology Market (2008-2012) Asia Pacific Biotechnology Market (2008-2012) PDF Format Asia Pacific Biotechnology Market (2008-2012) Published : June 2011 No.of Pages : 165 :: Enquire before buying :: Email to a friend Free Market Research Reports Alerts Register Now :: Printer friendly page Quick Buy Area Price : US$ 1,552.00 Add to Cart - (Asia Pacific Biotechnology Market (2008-2012)) Site License : US$ 2,328.00 Add to Cart - (Asia Pacific Biotechnology Market (2008-2012)) Change Currency : usd gbp eur Bookmark and Share Buy through us and save. We do not add any Tax / Duty including VAT,GST Asia Pacific Biotechnology Market (2008-2012) The Asia Pacific biotechnology market is one with immense potential, which can be tapped through investments driving the infrastructure and R&D in the sector. Investments in the past have been the main reason behind the sustained double digit growth in the biotech sector of the region.

"North America Super Critical Fluid Chromatography (Reagents) Market provides pictorial methodology along with detailed sizing by capturing all dependent markets. Super Critical Fluid Chromatography Reagents-North America can be segmented by Companies, Applications, Products, Processes, MacroIndicators and Endusers. Companies of Super Critical Fluid Chromatography Reagents-North America are Agilent Technologies, Phenomenex, Inc., GE Healthcare, W.R. Grace & Co., Helena Laboratories, Thermo Fisher Scientific, Waters Corporation and Other Companies." http://www.prweb.com/releases/fluid-chromatography/market/prweb12082364.htm

"North America Super Critical Fluid Chromatography (Reagents) Market provides pictorial methodology along with detailed sizing by capturing all dependent markets. Super Critical Fluid Chromatography Reagents-North America can be segmented by Companies, Applications, Products, Processes, MacroIndicators and Endusers. Companies of Super Critical Fluid Chromatography Reagents-North America are Agilent Technologies, Phenomenex, Inc., GE Healthcare, W.R. Grace & Co., Helena Laboratories, Thermo Fisher Scientific, Waters Corporation and Other Companies."

Oral health segment on a growth drive, thanks to the rising global awareness Oral healthcare industry includes various products which are toothpaste,

The Specialty Insurance market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In India market, the top players include: * United Healthcare * AXA * Allianz * AIG * Tokio Marine * ACE & Chubb * China Life